FXYD3 and breast carcinoma: Chemotherapeutic compounds, such as doxorubicin, can induce oxidative stress, and Liu et al., 2022, showed that the suppression of FXYD3 with siRNA in pancreatic and breast cancer cells, which strongly express FXYD3, increased doxorubicin-induced cytotoxicity.